Illumina announced on June 23, 2025, it will acquire SomaLogic from Standard BioTools for $350 million upfront, plus up to $75 million in near-term performance-based milestones and royalties123.
The deal also includes up to $425 million in potential total proceeds for Standard BioTools, and Illumina gains SomaLogic’s proteomics platforms and lab services25.
The acquisition accelerates Illumina’s multiomics strategy and expands its presence in the growing proteomics market13.
Sources:
1. https://www.prnewswire.com/news-releases/illumina-to-acquire-somalogic-accelerating-its-proteomics-business-and-advancing-the-companys-multiomics-strategy-302488151.html
2. https://www.genomeweb.com/sequencing/illumina-acquire-somalogic-assets-standard-biotools-425m
3. https://www.fiercebiotech.com/medtech/illumina-picks-proteomics-developer-somalogic-standard-biotools-425m
5. https://www.globenewswire.com/news-release/2025/06/23/3103269/0/en/Standard-BioTools-Enters-Next-Phase-of-Transformation-with-Strategic-Sale-of-SomaLogic-to-Illumina.html